Related Experiment Videos
Preventive effects of danazol on endometrial carcinogenesis in mice
K Niwa1, M Hashimoto, S Morishita
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, 40 Tsukasa-machi, 500-8705, Gifu, Japan. kniwa@cc.gifu-u.ac.jp
Abstract:
Short and long-term experiments were designed to determine effects of danazol on estrogen-related endometrial carcinogenesis in mice. The short-term assays showed that danazol decreased expression levels of c-fos/jun mRNA and their oncoproteins induced by estradiol-17beta (E2). For the long-term assay, 85 female ICR mice were given N-methyl-N-nitrsourea solution into their uterine corpora. The animals were divided into three groups as follows: Group 1, E2-diet (5 ppm) plus danazol (2 mg/body (s.c.), every 4 weeks); Group 2, E2-diet alone, Group 3, basal diet alone. At 30 weeks, incidences of atypical and complex endometrial hyperplasia were significantly decreased by danazol-treatment. These results suggest that danazol has preventive effects on estrogen-related endometrial carcinogenesis in mice, through the suppression of estrogen-induced c-fos/jun-expression.
Insights
Danazol demonstrates preventive effects against estrogen-induced endometrial cancer in mice by suppressing c-fos/jun expression. This study highlights danazol
Area of Science:
- Endocrinology
- Oncology
- Pharmacology
Background:
- Estrogen plays a critical role in endometrial carcinogenesis.
- Understanding modulators of estrogen-related endometrial proliferation is crucial for cancer prevention.
- Estradiol-17beta (E2) can induce c-fos/jun expression, implicated in endometrial changes.
Purpose of the Study:
- To investigate the preventive effects of danazol on estrogen-related endometrial carcinogenesis in a mouse model.
- To elucidate the molecular mechanisms underlying danazol's potential protective action.
Main Methods:
- Short-term assays assessed danazol's impact on estradiol-17beta (E2)-induced c-fos/jun mRNA and oncoprotein levels.
- A long-term study involved 85 female ICR mice treated with N-methyl-N-nitrosourea, followed by E2-diet with or without danazol.
- Incidences of endometrial hyperplasia were evaluated at 30 weeks.
Main Results:
- Short-term assays revealed danazol decreased E2-induced c-fos/jun expression.
- Long-term study showed danazol significantly reduced atypical and complex endometrial hyperplasia.
- Danazol treatment inhibited estrogen-related endometrial changes.
Conclusions:
- Danazol exhibits preventive effects against estrogen-related endometrial carcinogenesis in mice.
- The mechanism involves the suppression of estrogen-induced c-fos/jun expression.
- Danazol shows promise as a chemopreventive agent for endometrial abnormalities.